Working with industry on game changing solutions

ViceBio and the Rapid Response Vaccine Pipeline

Due to the work of Professor Keith Chappell and his research group, the AIBN has the knowledge and infrastructure to ensure Australia can develop and deliver clinical-grade vaccines whenever, and wherever, they are needed.

Meet our industry innovators

Founded in 2004, the AIBN, proudly based within The University of Queensland (UQ), has a unique outward facing operating model that fosters strong industry partnerships to enable translation and prepares the next generation of entrepreneurial scholars.

Innovating plasma and therapies with AEGROS

Creating batteries of the future with Redflow

Regenerative wound healing and preventing scar formation with HBI

Greener, safer, longer-life alternative to lithium batteries

Join The Network

Stay on top of our industry news and developments, events and opportunities, by joining The Network

ViceBio and the Rapid Response Vaccine Pipeline

Due to the work of Professor Keith Chappell and his research group, the AIBN has the knowledge and infrastructure to ensure Australia can develop and deliver clinical-grade vaccines whenever, and wherever, they are needed.
Chemical capture Remediating contamination with new materials

AIBN researchers are developing new, cost effective technologies to remediate and protect even the most remote sites and waterways that have been contaminated by the family of ‘forever chemicals’ known as perfluorinated compounds (PFAS).
Energy storage: Solving the clean energy puzzle

AIBN researchers have created world leading ‘quantum dot’ technology for electricity conversion to deliver significant upgrades on traditional solar cell technology, changing the game for a range of consumer and energy applications.
Designed Nanomaterials: Nanostructured materials for advancing technology

AIBN researchers are working with international colleagues to advance the design and synthesis of nanomaterials critical to the next generation of renewable energy, environmental, and biomedical technologies.
BASE facility: engineering a new generation of therapies and treatments

As the biggest supplier of mRNA vaccines and therapies for research in Australia, the AIBN’s BASE facility is well-positioned to lead the world in mRNA translation for biotechnology firms.

Footer TBA

Latest case study

ViceBio and the Rapid Response Vaccine Pipeline

Meet our industry innovators

Join The Network

Advanced biomanufacturing case studies

ViceBio and the Rapid Response Vaccine Pipeline

Chemical capture Remediating contamination with new materials

Energy storage: Solving the clean energy puzzle

Designed Nanomaterials: Nanostructured materials for advancing technology

BASE facility: engineering a new generation of therapies and treatments